Middle East map piece with highlighted Saudi Arabia, United Arab Emirates and image of the brain near it

Changing the narrative: Alzheimer's in the Middle East

Alzheimer’s disease has a significant social and economic impact on the Middle East. Policy briefs, informed by analysis and expert insight, lay out how health systems can prepare for early detection and deliver care to support Alzheimer’s patients.

13 September 2025

Elly Vaughan
Principal, Health, Economist Enterprise

Alzheimer’s Disease (AD), the most common form of dementia, is a neurodegenerative condition that leads to cognitive decline, robbing individuals of their memory, independence and ability to perform daily activities. Despite advances in diagnostics and treatments, AD is still often considered a condition with no hope. However, early diagnosis, improved care pathways and evidence-based policy interventions can improve people's quality of life and ease the burden of the condition.

With an ageing population, AD diagnoses in the Middle East are expected to increase, forcing AD as a public health priority. This research, which incorporates findings from a policy scan, desk research and a series of expert interviews, provides an overview of national efforts to address AD in Saudi Arabia and the United Arab Emirates. The country profiles below explore the current policy environment and state of care, highlighting opportunities to improve the response to AD and provide better support to those affected by the disease.